NDC 80687-010

Vontee

Silicon Dioxide, Tetrasodium Pyrophosphate, Pyridoxine Hydrochloride, Sodium Flouride

Vontee is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Vonjil. The primary component is Silicon Dioxide; Sodium Pyrophosphate; Pyridoxine Hydrochloride; Sodium Fluoride.

Product ID80687-010_27b32b01-48cf-4892-8843-99689d5b4793
NDC80687-010
Product TypeHuman Otc Drug
Proprietary NameVontee
Generic NameSilicon Dioxide, Tetrasodium Pyrophosphate, Pyridoxine Hydrochloride, Sodium Flouride
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-10-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameVONJIL
Substance NameSILICON DIOXIDE; SODIUM PYROPHOSPHATE; PYRIDOXINE HYDROCHLORIDE; SODIUM FLUORIDE
Active Ingredient Strength5 g/100g; g/100g; g/100g; g/100g
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 80687-010-02

1 CONTAINER in 1 CARTON (80687-010-02) > 21 g in 1 CONTAINER (80687-010-01)
Marketing Start Date2020-10-01
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [Vontee]

Mark Image

Registration | Serial
Company
Trademark
Application Date
VONTEE
VONTEE
90866101 not registered Live/Pending
PARK, SANGYONG
2021-08-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.